Sanofi Pasteur #49281057415 BEYFORTUS™ Respiratory Syncytial Virus Vaccine Nirsevimab-alip Indicated for People from Birth Through 24 Months of Age 100 mg / mL Injection Prefilled Syringe 0.5 mL BEYFORTUS, PFS 100MG/ML (5/BX) Features BEYFORTUS is a respiratory syncytial virus (RSV) F protein‑directed fusion inhibitor indicated for the prevention of RSV lower respiratory tract disease BEYFORTUS is an antibody that contains nirsevimab-alip which is used to help prevent RSV disease for 5 months Indicated for Newborns and babies under 1 year of age born during or entering their first RSV season, and children up to 24 months of age who remain at risk of severe RSV disease through their second RSV season For Intramuscular Injection Only Manufacturer # 49281057415 Brand BEYFORTUS™ Manufacturer Sanofi Pasteur Country of Origin Unknown Application Respiratory Syncytial Virus Vaccine Container Type Prefilled Syringe Dosage Form Injection Generic Drug Name Nirsevimab-alip NDC Number 49281057415 Product Dating Acceptable Dating: we will ship >= 180 days Storage Requirements Requires Refrigeration Strength 100 mg / mL Type Intramuscular User Indicated for People from Birth Through 24 Months of Age Volume 0.5 mL
Size: 100MG
More Information
